Innoviva announced the creation of Nortiva Bio, a new entity that will build on Langer Lab assets rescued after the collapse of Lyndra Therapeutics. The company aims to develop long‑acting oral medicines and explore drug development alliances.
Innoviva has launched Nortiva Bio, using rescued Langer Lab assets to develop long‑acting oral medicines and seek drug development alliances.
Compilé par l'équipe Pharmacountry · Source : FiercePharma
Laissez votre note